Company

Product

Description

Indication

Status

Proteus Digital Health Inc., of Redwood City, Calif.

Digimeds

Medications with ingestible sensors

Treatment of hepatitis C patients at high risk for nonadherence

Presented results from a study examining the impact of a digital medicine program on the efficacy of and adherence to direct-acting antivirals in hepatitis C patients at high risk for nonadherence; prospective, single-arm, open-label, multicenter study of 288 adults showed 99% of participants with sustained virologic response assessed > 10 weeks after completion of therapy achieved SVR; overall mean adherence rate was 95% and patient satisfaction was more than 80%


Notes

For more information about individual companies and/or products, see Cortellis.

No Comments